Comparative Study: Analog Devices And Industry Competitors In Semiconductors & Semiconductor Equipment Industry
In the dynamic and fiercely competitive business environment, conducting a thorough analysis of companies is crucial for investors and industry enthusiasts. In this article, we will perform an extensive industry
Chip stocks rebound after eight-session selloff
On Oct. 19, the Philadelphia Semiconductor Index gained 1.6%, ending an eight-session losing streak during which it fell about 15.7%. Reuters said concerns that higher rates could curb AI-infrastructure investment had pressured chipmakers; the rebound followed the selloff.
Needham reiterated Buy and $15 target
On October 19, Needham analyst Serge Belanger reiterated Buy and maintained his $15 price target. No old-to-new target change was reported. CRMD closed October 30 at $5.70, down 25.39%; no consensus-versus-actual earnings report fell within the period.
Thomson Reuters provides revised financial information after Global Print transaction
On October 19, 2026, following the October 1 sale of a 51% Global Print stake to KKR, Thomson Reuters said the business would be reported as discontinued operations from Q3 and prior periods restated. On the revised basis, prior Q3 outlook was ~9% organic revenue growth and ~35% adjusted EBITDA margin. Westbridge Print royalty is 20% of Professional revenue; revised FY2026 outlook due November 3.
InoBat and ADI announce MOU to explore battery storage platform for AI data centers
On October 19, 2026, ADI’s newsroom listed InoBat’s MOU announcement to explore i-Power+, an intelligent battery storage platform for AI data centers. The item is an exploration announcement; the newsroom listing provides no financial terms, customer commitments or quantified commercial impact.
Siebert Williams Shank raises EOG price target to $213 from $190
On October 19, 2026, Gabriele Sorbara of Siebert Williams Shank reiterated Buy and raised the target from $190 to $213. The source lists no stock or peer reaction.
IDEXX court case: default set aside in former employee’s disability-discrimination action
On October 16, the U.S. District Court for the District of Maryland issued an order in Lovey McClain v. IDEXX Laboratories, a disability-discrimination action against the company. The order concerns procedural motions; the available page does not state a damages amount.
Morgan Stanley kept Underweight rating, raised Emerson price target
On Oct. 19, Morgan Stanley analyst Chris Snyder maintained an Underweight rating on Emerson and raised the price target to $145 from $135.
Morgan Stanley raises Emerson target to $145, keeps Underweight
On October 19, Morgan Stanley analyst Chris Snyder raised his target from $135 to $145 and maintained Underweight. EMR closed October 30 at $164.94, down 3.40% that day; the source did not attribute the move to company-specific news.
CDW 8-K (5.02, 7.01, 9.01): director or officer change
CDW appointed former Deloitte Consulting & Advisory global CEO Sam Balaji to its Board of Directors, effective October 15, 2026; he brings more than three decades of technology, advisory and global business leadership experience.
Resmed Launches AirTouch™ F40 Full Face Fabric CPAP Mask in the U.S.
Resmed Launches AirTouch™ F40 Full Face Fabric CPAP Mask in the U.S.（摘要待生成）
CorMedix 8-K (7.01, 9.01): Regulation FD disclosure
CorMedix said the FDA accepted for Priority Review its partner Mundipharma’s supplemental application for REZZAYO to prevent invasive fungal disease, setting a target decision date in Q1 2027; if approved, the company aims to begin promotional efforts in the second half of 2027.
AES 8-K (8.01): other events
AES said the European Commission unconditionally approved its proposed merger on October 15, 2026, and New York’s Public Service Commission ruled October 19 that no further review is required; closing remains subject to additional regulatory approvals and customary conditions.
Paychex launches payroll tax penalty protection service
On October 19, 2026, Paychex announced a Tax Penalty Protection Service intended to help businesses manage payroll-tax matters and related penalties. No consensus-versus-actual figures or stock reaction were reported on the source page.
Wells Fargo raises Welltower price target to $268 from $266
On 2026-10-19, Wells Fargo analyst James Feldman maintained an Overweight rating and raised the price target from $266 to $268.
TD Cowen raises Analog Devices target to $475 from $460
On October 19, 2026, TD Cowen analyst Joshua Buchalter raised the price target to $475 from $460 and maintained Buy. The report did not give a rationale, consensus-versus-actual comparison, or stock and peer reaction.
Wedbush Raises Price Target on VeriSign to $351
Wedbush Securities has increased its price target for VeriSign, Inc. from $341 to $351 while maintaining an "Outperform" rating.
Williams-Sonoma, Inc. Appoints Lynn Martin to Board of Directors
Williams-Sonoma, Inc. has announced the appointment of Lynn Martin, President of NYSE Group, to its Board of Directors.
SiebertWilliams Shank Raises Devon Energy Price Target to $71
Analyst Gabriele Sorbara of SiebertWilliams Shank has maintained a 'Buy' rating on Devon Energy while increasing the price target to $71 from $64.
SEC 8-K filed 2026-10-19 (items 5.02, 7.01, 9.01)
CDW Appoints Sam Balaji to Board of Directors Former Global CEO, Deloitte Consulting & Advisory brings extensive experience in technology and services, transformation and global business leadership VERNON HILLS, Ill. – (BUSINESS WIRE) – CDW (Nasdaq: CDW), the strategic end-to-end technology partner that turns customer ambition into outcomes, today announced the appointment of Sam Balaji to its Board of Directors, effective October 15, 2026. Balaji brings more than three decades of experience in
Health-care stocks rally amid midterm-related policy expectations
Published Oct. 19, Axios reported the S&P 500 health-care sector was up more than 9% over three months and HCA and UHS had gained, amid investor expectations that a change in congressional control after the Nov. 3 election could delay or moderate scheduled Medicaid hospital reimbursement cuts. Analysts also cited defensive-sector rotation; the article cautioned the rally could not be attributed so